Form 4: Zimmer Biomet SVP Lori Winkler Reports Stock Transactions Following RSU Vesting

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units (RSUs) and subsequent transactions involving common stock.

Summary

• On February 14, 2025, Lori Winkler earned 7,208 Restricted Stock Units (RSUs) based on performance between 2022 and 2024, which vested on February 18, 2025.
• On February 18, 2025, Winkler exercised 7,208 RSUs, receiving 7,208 shares of Zimmer Biomet common stock.
• Also on February 18, 2025, 1,802 shares were withheld by Zimmer Biomet to cover tax obligations related to the RSU vesting at a price of $101.
• Following these transactions, Winkler directly owns 8,769 shares of Zimmer Biomet common stock and 7,208 RSUs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• Executive compensation packages often include RSUs as a way to align management's interests with those of shareholders.
• The vesting of RSUs based on performance metrics is a common practice to incentivize executives to achieve specific company goals.
• Tax withholding on RSU vesting is a standard procedure.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect changes in insider ownership.
• Employees may be interested in the details of executive compensation.

Key Dates

Keywords

Zimmer Biomet, Lori Winkler, RSU, Restricted Stock Units, Form 4, Stock Transaction, Vesting, SVP, CHRO